PDCD1 and non-small cell lung carcinoma: Artificial intelligence (AI)-assisted enhanced computed tomography (CT) was employed for the analysis of 1055 primary and metastatic lesions derived from patients diagnosed with advanced melanoma and NSCLC who underwent anti-PD-1 therapy.